Eris Lifesciences Ltd Secures Working Capital Term Loan of ₹ 64 Crore from Axis Bank
Eris Lifesciences Ltd has drawn down a working capital term loan amounting to ₹ 64,40,00,000/- (Rupees Sixty Four Crores Forty Lakhs Only) from Axis Bank Limited. The facility was secured to meet the company's short-term liabilities.
The agreement details reflect that Eris Lifesciences and Axis Bank Limited are the parties involved in the transaction. The loan was drawn down following a sanction letter executed on August 5, 2026.
According to the agreement details, the total amount sanctioned for this financing facility is ₹ 64,40,00,000/- (Rupees Sixty Four Crores Forty Lakhs Only).
Key aspects of the loan agreement between Eris Lifesciences Ltd and Axis Bank Limited include:
| Aspect | Detail |
|---|---|
| Lender/Borrower | Axis Bank Limited / Eris Lifesciences Limited |
| Nature of Transaction | Working Capital Term Loan and Working Capital Loan |
| Total Amount Granted | ₹ 64,40,00,000/- (Rupees Sixty Four Crores Forty Lakhs Only) |
| Sanction Date | August 5, 2026 |
| Financial Impact | The company's aggregate debt level would remain unchanged. |
The transaction involves Axis Bank Limited and Eris Lifesciences Ltd, with no shareholding mentioned in the agreement concerning the lending party. The loan is secured by a second charge on assets (both primary and collateral) already created for both parties.
ERIS Stock Price Movement
As of 9:41 AM, shares of Eris Lifesciences Limited are climbing slightly, currently trading at ₹1382 after edging up by 0.50%. The equity's intraday movement holds within a tight range between ₹1368.5 and ₹1385.1, with 9,146 shares traded so far in the live market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.